Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

GZMB anticorps (AA 21-247)

Cet anticorps anti-GZMB est un anticorps Souris Monoclonal détectant GZMB dans BCA. Adapté pour Humain.
N° du produit ABIN2666249

Aperçu rapide pour GZMB anticorps (AA 21-247) (ABIN2666249)

Antigène

Voir toutes GZMB Anticorps
GZMB (Granzyme B (GZMB))

Reactivité

  • 161
  • 51
  • 26
  • 12
  • 4
  • 4
  • 3
  • 1
  • 1
Humain

Hôte

  • 90
  • 77
  • 3
Souris

Clonalité

  • 87
  • 83
Monoclonal

Conjugué

  • 89
  • 15
  • 9
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp GZMB est non-conjugé

Application

  • 86
  • 68
  • 50
  • 43
  • 22
  • 19
  • 18
  • 18
  • 14
  • 13
  • 11
  • 10
  • 6
  • 6
  • 5
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Biochemical Assay (BCA)

Clone

O94E6-GZMB
  • Épitope

    • 31
    • 17
    • 16
    • 11
    • 11
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 21-247

    Purification

    The antibody was purified by affinity chromatography.

    Immunogène

    AA 21-247 of Human Granzyme B produced in E. coli.

    Isotype

    IgG2a
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    0.5 mg/mL

    Buffer

    Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    Upon receipt, store undiluted at 4°C
  • Antigène

    GZMB (Granzyme B (GZMB))

    Autre désignation

    Granzyme B

    Sujet

    Granzyme B is a serine protease that is produced mainly by cytotoxic T cells (CTL) and natural killer (NK) cells. It plays an important role in cytotoxic lymphocyte-mediated apoptosis, chronic inflammation, and impaired wound healing. Granzyme B is packaged in cytoplasmic granules that are exocytosed towards a bound target cell, which subsequently activates multiple protein substrates that induce apoptosis. Perforin facilitates the transfer of Granzyme B into the target cell. Most circulating CD56+, CD8-, NK cells, and approximately half of circulating CD8+ T cells coexpress both Granzyme A and B. The activation of CD8+ and CD4+ T lymphocytes induce substantial expression of Granzyme B, but not Granzyme A. Recently, Granzyme B has been found to be produced by other cell types such as CD34+ hematopoietic progenitor cells, keratinocytes, basophils, mast cells, plasmacytoid dendritic cells, B cells, and smooth muscle cells. Elevated levels of Granzyme B are also found in some kinds of autoimmune diseases, type 1 diabetes, and cardiovascular diseases.

    Pathways

    Apoptose, Caspase Cascade in Apoptosis
Vous êtes ici:
Chat with us!